Literature DB >> 23323278

NICE guidance on denosumab for prevention of skeletal-related events in adults with bone metastases from solid tumours.

Anwar Jilani, Zoe Garrett, Frances Sutcliffe, Andrew Stevens.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23323278     DOI: 10.1016/s1470-2045(12)70470-9

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  3 in total

Review 1.  Denosumab and giant cell tumour of bone-a review and future management considerations.

Authors:  S F Xu; B Adams; X C Yu; M Xu
Journal:  Curr Oncol       Date:  2013-10       Impact factor: 3.677

2.  The Use of Denosumab in a Nonagenarian with Primary Hyperparathyroidism.

Authors:  Tamer Shalaby; Samantha Anandappa; Siva Sivappriyan; Jesse Kumar
Journal:  Eur Endocrinol       Date:  2014-08-28

3.  A meta-analysis of the antitumor effect and safety of bisphosphonates in the treatment of multiple myeloma.

Authors:  Xiaoxue Wang; Xiaojing Yan; Yan Li
Journal:  Int J Clin Exp Med       Date:  2015-05-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.